CorrespondenceMultidrug-resistant tuberculosis
References (6)
- et al.
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Lancet Infect Dis
(2010) Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Lancet
(2018)- et al.
Classification of anti-TB drugs: a new potential proposal based on the most recent evidence
Eur Respir J
(2015)
There are more references available in the full text version of this article.
Cited by (5)
Update of SEPAR guideline «Diagnosis and Treatment of Drug-Resistant Tuberculosis»
2020, Archivos de BronconeumologiaChina's unique role in the field of global health
2019, Journal of Global HealthCitation Excerpt :Traditional infectious diseases such as tuberculosis, malaria, and AIDS are resurfacing and spreading. As a result of the increasingly serious abuse of antibiotics, the types of multidrug-resistant pathogens have also increased.6–8 As people's behaviors and lifestyles have changed, the chronic non-communicable diseases have become more common in developing countries.
Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review
2023, Journal of Biomolecular Structure and Dynamics
© 2019 Elsevier Ltd. All rights reserved.